Cargando…
Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma
Autores principales: | de Mel, Sanjay, Rashid, Masturah B. M., Zhang, Xi Yun, Goh, Jasmine, Lee, Chun Tsu, Poon, Li Mei, Chan, Esther H. L., Liu, Xin, Chng, Wee Joo, Chee, Yen Lin, Lee, Joanne, Yuen, Yi Ching, Lim, Jing Quan, Chia, Burton K. H., Laurensia, Yurike, Huang, DaChuan, Pang, Wan Lu, Cheah, Daryl Ming Zhe, Wong, Esther Kam Yin, Ong, Choon Kiat, Tang, Tiffany, Lim, Soon Thye, Ng, Siok Bian, Tan, Soo Yong, Loi, Hoi-Yin, Tan, Lip Kun, Chow, Edward K., Jeyasekharan, Anand D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985240/ https://www.ncbi.nlm.nih.gov/pubmed/31988286 http://dx.doi.org/10.1038/s41408-020-0276-7 |
Ejemplares similares
-
Evaluation of the PIK3 pathway in peripheral T‐cell lymphoma and NK/T‐cell lymphoma
por: Huang, Dachuan, et al.
Publicado: (2020) -
A clinicohaematological prognostic model for nasal-type natural killer/T-cell lymphoma: A multicenter study
por: Tan, Khee Ming, et al.
Publicado: (2019) -
No association between ECSIT germline mutations and hemophagocytic lymphohistiocytosis in natural killer/T-cell lymphoma
por: Ong, Shin Yeu, et al.
Publicado: (2020) -
Evolving therapeutic landscape of diffuse large B-cell lymphoma: challenges and aspirations
por: Chan, Jason Yongsheng, et al.
Publicado: (2023) -
Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders
por: de Mel, Sanjay, et al.
Publicado: (2019)